- We are committed to evidence-based practice
- We value the opportunity to collaborate with independent researchers
- Where a collaborator proposes research (investigator initiated project) our preference is that s/he acts as principal investigator (PI)
- We prioritize protocols that are likely to advance the field
- Protocols must be open to external review
- Protocols must be subject to appropriate ethical approvals, clinical governance arrangements , and trials registration
- Data will be handled and stored in keeping with regulatory guidelines
- Data will be made available directly to the PI and co-investigators for the purpose of independent analysis
- Expert statistical advice should be engaged whenever possible
- Active protocols must have a Steering Group and must be subject to periodic review
- Continued engagement with a project depends upon satisfactory progress reports, wherever possible using existing procedures (e.g. annual report/ review with funder)
- We reserve the right to disengage from research that ceases to be ethical, feasible or cost efficient
- Research outputs should be published in leading scientific journals, regardless of commercial interests
- Intellectual property (IP) associated with the Sleepio platform and its services shall at all times remain with Sleepio
- Where external, non-commercial, collaboration is sought, Sleepio resources will be provided on a cost/ not-for-profit basis
- Where commercial collaboration is anticipated, agreements will be put in place on a case by case basis
- Non-commercial projects will be prioritized over commercial projects
- The most contemporary version(s) of the Sleepio program will be provided and should be utilized in collaborative projects, including updates during the course of a study
- All projects utilizing Sleepio resources should be appropriately declared/ acknowledged
- Prof Colin A Espie BSc, MAppSci, PhD, CSci, CPsychol, FBPsS Clinical & Scientific Director, Sleepio
- Clinical & Scientific Director, Sleepio